热冲击蛋白47的下调导致了溶酶体功能障碍,导致过度的冠状细胞亡
Yawen Shi1, Ying He1, Yanan Li2
1School of Public Health, Xi'an Jiaotong University, Key Laboratory of Environment and Genes Related to Diseases in the Education Ministry and Key Laboratory of Trace Elements and Endemic Diseases in Ministry of Health, Xi'an, Shaanxi, 710061, China.
Experimental cell research
|October 24, 2024
概括
热冲击蛋白47 (HSP47) 对于体细胞的溶解体功能至关重要. 它的下调会破坏溶解体,损害自,并导致细胞死亡,突出显示HSP47在细胞存活中的作用.
科学领域:
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 热冲击蛋白47 (HSP47) 是一种特定于原蛋白的伴侣,参与蛋白质折叠.
- 升高的HSP47与癌症和纤维化有关,但其在下调时对状细胞健康的作用尚不清楚.
- 溶酶体功能障碍和自功能障碍与各种细胞病理有关.
研究的目的:
- 研究HSP47下调对状细胞溶解体和自-溶解体通路的后果.
- 确定HSP47在维持 lysosomal 稳态和预防冠状细胞亡中的作用.
- 探索恢复 lysosomal 功能的治疗潜力.
主要方法:
- 产生了带有shRNA的lentiviral载体,以稳定降低ATDC5红细胞中的HSP47.
- 分析了溶酶体形态,酸度,水解酶活性和自-溶酶体路径标记物.
- 利用 lysosomal 抑制剂 CA-074 Me 评估其对 HSP47 下调的红细胞的影响.
主要成果:
- 低调 HSP47 干扰了 lysosomal 酸度,失调了水解酶活性,并损害了自 - lysosome 途径.
- 观察到异常的溶酶体形态,数量和效应蛋白表达.
- CA-074 我治疗部分挽救了溶酶体功能,减少了自性缺陷,并减少了状细胞亡.
结论:
- HSP47对于维持淋巴细胞中的溶酶体功能和自流量至关重要.
- 低调 HSP47 导致溶酶体功能障碍和亡,强调其保护作用.
- 恢复 lysosomal 功能可能是一个治疗策略,防止与 HSP47 相关的慢性细胞死亡.
相关概念视频
01:30Apoptosis
11.2K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
11.2K
01:22Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
01:17The Extrinsic Apoptotic Pathway
6.3K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.3K
01:31The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
01:31Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
01:13The Proteasome
815
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
815